IPO registrations (S-1, F-1) · Registrants
CHEMBIO DIAGNOSTICS, INC.
- SEC CIK
- 1092662 · filings on EDGAR ↗
- Former names
- Chembio Diagnostics Inc. (2004–2005); TRADING SOLUTIONS COM INC (1999–2004)
- Registration
- Form S-1, first filed 2010-03-25, last 2022-10-07; 2 initial registrations, 3 amendments
- Outcome
- Declared effective 2011-03-22; withdrawal requested 2010-08-02
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- NV
- Business address
- 555 WIRELESS BLVD., Hauppauge, NY 11788
- EIN
- 88-0425691
- EDGAR entity type
- operating
- Insiders and CEO pay
- CHEMBIO DIAGNOSTICS, INC. on the corporate pages
Offering terms
- Shares offered
- 40,476,190
- Listing
- Nasdaq under the symbol CEMI
- Lead underwriters
- Craig-Hallum
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CHEMBIO DIAGNOSTICS, INC. Fuzzy (name and state)
- Lobbying client: CHEMBIO DIAGNOSTICS Fuzzy (name and state)
- Lobbying client: CHEMBIO DIAGNOSTICS Fuzzy (name and state)
- Lobbying client: CHEMBIO DIAGNOSTICS, INC. Fuzzy (name and state)
- Lobbying client: CHEMBIO DIAGNOSTICS, INC. Fuzzy (name and state)
- SEC filer: CHEMBIO DIAGNOSTICS, INC. EXACT (CIK (EXACT))
- Person page: Barbara A Debuono Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 18
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-03-25 | S-1 | S-1 (registration) | CHEMBIO DIAGNOSTICS, INC. | 0001092662-10-000033 ↗ |
| 2010-05-25 | S-1/A | S-1/A (amendment) | CHEMBIO DIAGNOSTICS, INC. | 0001092662-10-000061 ↗ |
| 2010-08-02 | RW | RW (withdrawal request) | CHEMBIO DIAGNOSTICS, INC. | 0001092662-10-000087 ↗ |
| 2011-03-22 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-11-000732 ↗ |
| 2013-01-25 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-13-000288 ↗ |
| 2016-04-05 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-16-004142 ↗ |
| 2017-02-09 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-17-000347 ↗ |
| 2018-10-03 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-18-002536 ↗ |
| 2021-05-05 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-21-001819 ↗ |
| 2022-09-07 | S-1 | S-1 (registration) | CHEMBIO DIAGNOSTICS, INC. | 0001140361-22-032630 ↗ |
| 2022-09-28 | S-1/A | S-1/A (amendment) | CHEMBIO DIAGNOSTICS, INC. | 0001140361-22-034996 ↗ |
| 2022-10-07 | S-1/A | S-1/A (amendment) | CHEMBIO DIAGNOSTICS, INC. | 0001140361-22-036674 ↗ |
| 2023-04-27 | RW | RW (withdrawal request) | CHEMBIO DIAGNOSTICS, INC. | 0001140361-23-021053 ↗ |
| 2023-05-02 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-23-001214 ↗ |
| 2023-05-02 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-23-001215 ↗ |
| 2023-05-02 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-23-001216 ↗ |
| 2023-05-02 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-23-001217 ↗ |
| 2023-05-02 | EFFECT | EFFECT (declared effective) | CHEMBIO DIAGNOSTICS, INC. | 9999999995-23-001218 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-07 | S-1/A | registration statement | $0.01 | 40,476,190 | $404,761 | Nasdaq CEMI | 1 | primary document; price line, shares headline, proceeds computed, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Siebert Lawrence A. | Director,Officer,TenPercentOwner; Other | CEO; Chairman & President; Chief Executive Officer; President | 34 | 2006–2014 | |
| Larkin Richard J | Officer | CFO; Cheif Financial Officer; Chief Financial Officer | 21 | 2006–2017 | |
| Pelossof Avi | Officer | Vice President; VP Sales, Marketing & B.D.; VP Sales, Marketing & BD | 7 | 2006–2007 | |
| EPPNER GERALD A | Director | 1 | 2006 | ||
| Meller Gary | Director | 17 | 2006–2018 | ||
| Carus Alan | Director | 5 | 2006–2008 | ||
| CRESTVIEW CAPITAL MASTER LLC | TenPercentOwner | 9 | 2007–2010 | ||
| Esfandiari Javan | Officer | Chief Science and Technology O; Chief Science Technol. Officer; Chief Science/Technology Offic; Chief Science/Tech Officer; See Remarks; Senior Vice President; SVP, Research & Development; VP, Research & Development | 33 | 2007–2023 | |
| Davis Katherine Lyon | Director | 16 | 2007–2023 | ||
| Aromando Robert L | Officer | Sr VP, Commercial Operations; SVP, Commercial Operations | 3 | 2007–2008 | |
| Crestview Capital Partners, LLC | TenPercentOwner | 7 | 2007–2010 | ||
| Merselis James D | Director | 3 | 2008 | ||
| DeBuono Barbara A | Director | 5 | 2011–2016 | person page Fuzzy | |
| KISSINGER PETER | Director | 7 | 2011–2016 | ||
| Klugewicz Sharon W | Officer | Chief Operating Officer; President, Americas; See Remarks | 9 | 2013–2018 | |
| Sperzel John J III | Director,Officer; Officer | CEO; CEO / Director; See Remarks | 6 | 2014–2019 | |
| Pessin Brian L. | Other | 2 | 2017 | ||
| PESSIN NORMAN H | Other | 2 | 2017 | ||
| PAGE GAIL S | Director; Director,Officer | See Remarks | 5 | 2017–2020 | |
| Goldman Neil A | Officer | EVP & Chief Financial Officer; Executive VP and CFO; See Remarks | 5 | 2017–2021 | |
| Potthoff John Gary | Director | 7 | 2018–2023 | ||
| POLAN MARY LAKE PH D | Director | 3 | 2018–2020 | ||
| Gyorke David | Officer | See Remarks | 2 | 2018 | |
| Passas Robert | Officer | See Remarks | 4 | 2018–2020 | |
| EBERLY RICHARD | Director,Officer; Officer | See Remarks | 5 | 2020–2023 | |
| Acheson David | Director | 4 | 2020–2023 | ||
| Bespalko David William | Director | 4 | 2021–2023 | ||
| Steenvoorden Lawrence J. | Officer | See remarks | 3 | 2022–2023 | |
| Angelico Paul | Officer | See remarks | 2 | 2022–2023 | |
| Caso Charles | Officer | See remarks; See Remarks | 2 | 2022–2023 | |
| Teso-Lichtman Leslie | Director | 4 | 2022–2023 | ||
| EDELMAN JOSEPH | Other; TenPercentOwner | 7 | 2023 | ||
| PERCEPTIVE ADVISORS LLC | Other; TenPercentOwner | 7 | 2023 | ||
| Perceptive Credit Advisors, LLC | Other; TenPercentOwner | 7 | 2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | CHEMBIO DIAGNOSTICS, INC. | NY | State business registries | name and state |
| Lobbying client | CHEMBIO DIAGNOSTICS | NY | Federal lobbying (LDA) | name and state |
| Lobbying client | CHEMBIO DIAGNOSTICS | NY | Federal lobbying (LDA) | name and state |
| Lobbying client | CHEMBIO DIAGNOSTICS, INC. | NY | Federal lobbying (LDA) | name and state |
| Lobbying client | CHEMBIO DIAGNOSTICS, INC. | NY | Federal lobbying (LDA) | name and state |
| SEC filer | CHEMBIO DIAGNOSTICS, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Barbara A Debuono | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NY first:
- TG THERAPEUTICS, INC. NY
- SIGA TECHNOLOGIES INC NY
- SEELOS THERAPEUTICS, INC. NY
- Protagenic Therapeutics, Inc.\new NY
- XTL BIOPHARMACEUTICALS LTD NY
- PENWEST PHARMACEUTICALS CO NY
- EYETECH PHARMACEUTICALS INC NY
- INNOVATIVE DRUG DELIVERY SYSTEMS INC NY
- EON LABS INC NY
- ORAMED PHARMACEUTICALS INC. NY
In other datasets, the same topic (Health) in NY:
- Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health